By RAF CASERT Associated Press BRUSSELS (AP) — In a stinging rebuke to pharma giant AstraZeneca, the head of the European Union's executive arm has announced plans for a major contract extension for COVID-19 vaccines with Pfizer stretching to 2023. European Commission President Ursula von der Leyen said Wednesday that the EU will start negotiating to buy 1.8 billion doses of the Pfizer-BioNTech vaccine through 2023. It's been a mainstay of the EU's vaccination drive so far. Von der Leyen expressed full confidence in the technology used for the Pfizer-BioNTech vaccine. BRUSSELS (AP) — In a stinging rebuke to pharma […]

The post EU throws weight behind Pfizer-BioNTech and new technology appeared first on BNC.